home / stock / elev / elev quote
Last: | $2.72 |
---|---|
Change Percent: | 3.03% |
Open: | $2.69 |
Close: | $2.64 |
High: | $2.75 |
Low: | $2.6 |
Volume: | 203,464 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.72 | $2.69 | $2.64 | $2.75 | $2.6 | 203,464 | 07-22-2024 |
$2.64 | $2.65 | $2.64 | $2.78 | $2.62 | 443,117 | 07-19-2024 |
$2.67 | $2.89 | $2.67 | $2.895 | $2.63 | 775,361 | 07-18-2024 |
$2.89 | $2.9 | $2.89 | $3 | $2.826 | 493,298 | 07-17-2024 |
$2.995 | $3.06 | $2.995 | $3.28 | $2.98 | 843,196 | 07-16-2024 |
$3.02 | $2.93 | $3.02 | $3.04 | $2.87 | 743,775 | 07-15-2024 |
$2.88 | $2.72 | $2.88 | $2.955 | $2.65 | 1,261,983 | 07-12-2024 |
$2.7 | $2.72 | $2.7 | $2.76 | $2.635 | 3,896,369 | 07-11-2024 |
$2.64 | $2.62 | $2.64 | $2.75 | $2.55 | 690,596 | 07-10-2024 |
$2.63 | $2.77 | $2.63 | $2.82 | $2.54 | 1,750,519 | 07-09-2024 |
$2.79 | $2.88 | $2.79 | $3.05 | $2.6715 | 1,063,184 | 07-08-2024 |
$2.85 | $2.66 | $2.85 | $2.87 | $2.59 | 887,582 | 07-05-2024 |
$2.7 | $2.83 | $2.7 | $2.8399 | $2.61 | 401,142 | 07-04-2024 |
$2.7 | $2.83 | $2.7 | $2.8399 | $2.61 | 401,142 | 07-03-2024 |
$2.8 | $2.86 | $2.8 | $2.92 | $2.75 | 762,155 | 07-02-2024 |
$2.86 | $2.68 | $2.86 | $2.88 | $2.61 | 719,861 | 07-01-2024 |
$2.7 | $2.51 | $2.7 | $2.78 | $2.44 | 8,631,302 | 06-28-2024 |
$2.51 | $2.41 | $2.51 | $2.73 | $2.38 | 873,659 | 06-27-2024 |
$2.35 | $2.42 | $2.35 | $2.42 | $2.22 | 514,961 | 06-26-2024 |
$2.41 | $2.51 | $2.41 | $2.61 | $2.4 | 352,607 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Elevation Oncology Inc. Company Name:
ELEV Stock Symbol:
NASDAQ Market:
Elevation Oncology Inc. Website:
Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer PR Newswire -- Plan to evaluate EO-3021 in combination with ramucirumab and dostarlimab; entered into clinical supply agreements with Lilly and GS...
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference PR Newswire BOSTON , May 7, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therap...